Last reviewed · How we verify
Bladder instillation WITHOUT triamcinolone acetonide — Competitive Intelligence Brief
Target snapshot
Bladder instillation WITHOUT triamcinolone acetonide (Bladder instillation WITHOUT triamcinolone acetonide) — Olivia Cardenas-Trowers, M.D.. A bladder instillation therapy that delivers therapeutic agents directly into the bladder without triamcinolone acetonide to treat bladder conditions.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Bladder instillation WITHOUT triamcinolone acetonide TARGET | Bladder instillation WITHOUT triamcinolone acetonide | Olivia Cardenas-Trowers, M.D. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Bladder instillation WITHOUT triamcinolone acetonide CI watch — RSS
- Bladder instillation WITHOUT triamcinolone acetonide CI watch — Atom
- Bladder instillation WITHOUT triamcinolone acetonide CI watch — JSON
- Bladder instillation WITHOUT triamcinolone acetonide alone — RSS
Cite this brief
Drug Landscape (2026). Bladder instillation WITHOUT triamcinolone acetonide — Competitive Intelligence Brief. https://druglandscape.com/ci/bladder-instillation-without-triamcinolone-acetonide. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing